# Medtronic Endovascular clinical trials: 51 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 51 trials with Medtronic Endovascular as lead sponsor, 1 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Medtronic Endovascular: 51 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/medtronic-endovascular

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 51
- Recruiting or not yet: 1
- Read on: November 19, 2026

## Trials

The 25 newest of 51, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| June 10, 2026 | NCT07639853 | Case-Specific Health Care Professional Clinical Survey for Concerto Versa™ Detachable Coils | Medtronic Endovascular | Observational | Enrolling by invitation | Arteriovenous Malformation, Gastrointestinal Bleed, Gastric Varices, Hemorrhoid, Pelvic Venous Disorders, Peripheral... | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07639853) |
| January 13, 2026 | NCT07335341 | Case-Specific Health Care Professional Clinical Survey of Liberant™ Thrombectomy System | Medtronic Endovascular | Observational | Completed | Venous Embolism of Lower Extremities (Diagnosis), Arterial Embolism and Thrombosis, Acute DVT of Lower Extremity... | 51 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07335341) |
| December 19, 2024 | NCT06742801 | Onyx™ Liquid Embolic IDE Clinical Study | Medtronic Endovascular | Not applicable | Recruiting | Peripheral Arterial Hemorrhage, Trauma, GI Bleed, Ulcer, Hemorrhage | 119 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06742801) |
| July 31, 2020 | NCT04494035 | AVATR - Arteriovenous Access Thrombosis Removal With CAPERE Thrombectomy System | Medtronic Endovascular | Not applicable | Terminated | Arteriovenous Graft Thrombosis | 7 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04494035) |
| July 23, 2020 | NCT04484220 | Ellipsys Vascular Access System Post Market Surveillance (PS) Study | Medtronic Endovascular | Not applicable | Completed | Renal Disease, End Stage, Kidney Disease, End-Stage, AV Fistula, Fistulas Arteriovenous | 142 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04484220) |
| February 24, 2020 | NCT04282161 | Pivotal Study of the Medtronic Axys EX Rotational Atherectomy System | Medtronic Endovascular | Not applicable | Withdrawn | Peripheral Arterial Disease | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04282161) |
| October 9, 2019 | NCT04120610 | FlowMet-R Blood Flow Measurement for the Diagnosis of Peripheral Artery Disease and Critical Limb Ischemia | Medtronic Endovascular | Observational | Terminated | Peripheral Artery Disease | 195 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04120610) |
| March 11, 2019 | NCT03869645 | CAPERE Thrombectomy System Post-Market Clinical Follow Up Study | Medtronic Endovascular | Observational | Terminated | Observational Study | 18 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03869645) |
| January 29, 2019 | NCT03820947 | VenaSeal Spectrum: Global Post-Market Randomized Controlled Trial | Medtronic Endovascular | Not applicable | Terminated | Venous Reflux | 506 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03820947) |
| March 6, 2018 | NCT03455699 | VeClose Five Year Follow-Up Extension Study | Medtronic Endovascular | Observational | Completed | Great Saphenous Vein (GSV) With Venous Reflux Disease | 114 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03455699) |
| March 5, 2018 | NCT03454113 | Ellipsys Vascular Access System Registry | Medtronic Endovascular | Observational | Completed | End-stage Renal Disease | 17 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03454113) |
| February 2, 2017 | NCT03041467 | IN.PACT™ AV Access IDE Study | Medtronic Endovascular | Not applicable | Completed | Arteriovenous Fistula Stenosis, Arteriovenous Fistula Occlusion, Arteriovenous Fistula, Fistula | 330 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03041467) |
| January 31, 2017 | NCT03038438 | ABRE Clinical Study of the Abre Venous Self-expanding Stent System | Medtronic Endovascular | Not applicable | Completed | Iliofemoral Venous Obstruction | 260 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03038438) |
| November 15, 2016 | NCT02963649 | IN.PACT BTK Randomized Study to Assess Safety and Efficacy of IN.PACT 014 vs. PTA | Medtronic Endovascular | Not applicable | Completed | Critical Limb Ischemia, Peripheral Arterial Disease | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02963649) |
| June 28, 2016 | NCT02816398 | Catheter System Feasibility Clinical Trial | Medtronic Endovascular | Not applicable | Completed | Renal Insufficiency, Chronic | 26 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02816398) |
| February 16, 2015 | NCT02363972 | Percutaneous Less Invasive AV Fistula for Vascular Access in ESRD | Medtronic Endovascular | Not applicable | Completed | End Stage Renal Disease, AV Fistula, Fistula, End Stage Kidney Disease | 103 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02363972) |
| February 16, 2015 | NCT02363894 | DEFINITIVE AR Two Year Follow-up Extension Study | Medtronic Endovascular | Observational | Completed | Peripheral Arterial Disease | 53 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02363894) |
| June 23, 2014 | NCT02169921 | TurboHawk™ Japan Trial in Patients With PAD | Medtronic Endovascular | Not applicable | Completed | Peripheral Arterial Disease | 51 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02169921) |
| April 21, 2014 | NCT02118532 | The IN.PACT SFA Clinical Study for the Treatment of Atherosclerotic Lesions in the Superficial Femoral Artery and/or Proximal Popliteal... | Medtronic Endovascular | Not applicable | Completed | Atherosclerosis | 143 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02118532) |
| February 19, 2014 | NCT02066740 | EverFlex™ Self-expanding Peripheral Stent With Entrust™ Delivery System Clinical Study | Medtronic Endovascular | Not applicable | Completed | Peripheral Arterial Diseases | 34 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02066740) |
| September 20, 2013 | NCT01947478 | MDT-2113 Drug-Eluting Balloon vs. Standard PTA for the Treatment of Atherosclerotic Lesions in the Superficial Femoral Artery and/or... | Medtronic Endovascular | Not applicable | Completed | Femoral Artery Stenosis, Popliteal Artery Stenosis, Femoral Artery Occlusion, Popliteal Artery Occlusion | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01947478) |
| September 11, 2013 | NCT01939392 | Rapid Renal Sympathetic Denervation for Resistant Hypertension II | Medtronic Endovascular | Phase 2/3 | Withdrawn | Resistant Hypertension, Uncontrolled Hypertension, Renal Artery Ablation | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01939392) |
| May 1, 2013 | NCT01844037 | OneShot Renal Denervation Registry | Medtronic Endovascular | Phase 2/3 | Terminated | Hypertension, Heart Failure, Diabetes Mellitus, Sleep Apnea | 51 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01844037) |
| March 8, 2013 | NCT01807585 | VenaSeal Sapheon Closure System Pivotal Study (VeClose) | Medtronic Endovascular | Not applicable | Completed | Great Saphenous Vein (GSV) With Venous Reflux Disease | 242 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01807585) |
| September 7, 2012 | NCT01680835 | EverFlex Post Approval Study | Medtronic Endovascular | Not applicable | Completed | Peripheral Arterial Disease, Lower Extremity Arterial Disease | 108 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01680835) |

## By phase

| Phase | Trials |
| --- | --- |
| Early phase 1 | 1 |
| Phase 2/3 | 3 |
| Phase 3 | 1 |
| Phase 4 | 1 |
| Not applicable | 36 |
| Observational | 9 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 40 |
| Terminated | 7 |
| Withdrawn | 2 |
| Recruiting | 1 |
| Enrolling by invitation | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Peripheral Arterial Disease | 21 |
| Peripheral Vascular Diseases | 8 |
| Intermittent Claudication | 6 |
| Kidney Failure, Chronic | 4 |
| Chronic Limb-Threatening Ischemia | 4 |
| Vascular Diseases | 4 |
| Atherosclerosis | 4 |
| Arteriovenous Fistula | 3 |
| Carotid Artery Diseases | 3 |
| Gastrointestinal Hemorrhage | 2 |
| Hemorrhage | 2 |
| Hypertension | 2 |
| Renal Insufficiency, Chronic | 2 |
| Fistula | 2 |
| Varicose Veins | 2 |
| Arterial Occlusive Diseases | 2 |
| Wounds and Injuries | 1 |
| Ulcer | 1 |
| Heart Failure | 1 |
| Diabetes Mellitus | 1 |
| Sleep Apnea Syndromes | 1 |
| Erectile Dysfunction | 1 |
| Coronary Artery Disease | 1 |
| Stroke | 1 |
| Venous Insufficiency | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Farm equipment repair companies in the United States](https://specstream.ai/data/businesses/farm-equipment-repair-companies/united-states)
- [Argentine restaurants in the United States](https://specstream.ai/data/businesses/argentine-restaurants/united-states)
- [Playground equipment suppliers in the United States](https://specstream.ai/data/businesses/playground-equipment-suppliers/united-states)
- [Forklift dealers in the United States](https://specstream.ai/data/businesses/forklift-dealers/united-states)
- [B2B international trade companies in the United States](https://specstream.ai/data/businesses/b2b-international-trade-companies/united-states)
- [Psychiatry practices in the United States](https://specstream.ai/data/businesses/psychiatry-practices/united-states)
